
Apply to the 2026 NF Young Adult Leadership Program
Are you a passionate young adult looking to make a difference in your community? The NF Young Adult Leadership Program…
Read MoreCheck out past blogs and news!
Are you a passionate young adult looking to make a difference in your community? The NF Young Adult Leadership Program…
Read MoreHelp Improve NF1 Care!Even Your Own Right Now!Participants Needed! I’m lucky to be able to go to an NF clinic,…
Read MoreWelcome to Champions of the Fall! This is an exciting new fundraising and awareness campaign from NF Midwest, running from October…
Read MoreI Just Joined the NF1-TED Study — and You Might Want To, Too I recently enrolled in the NF1 Tumor…
Read MoreRecordings from the 2024 iNFo Fair are now posted on NF Midwest’s YouTube channel youtube.com/@nfmidwest. There may still be more…
Read MoreIf you or your child has NF1 and have not visited an NF Clinic Network (NFCN) clinic in the past…
Read MoreThree Months. One Champion. Rally Your Crew! NF Midwest has a new fall fundraising and awareness campaign kicking off on…
Read MoreA Collaboration with Children’s Tumor Foundation. The NSC ride is organized by the Evanston Bicycle Club. Join the NF Midwest…
Read MoreParticipants 40+ May Earn $40. Florida State University College of Medicine is conducting a study to investigate cognitive patterns and…
Read MoreParent’s May Earn $10. Kids 13-17 May Earn $210. Florida State University College of Medicine is conducting a study to…
Read MoreAre you a passionate young adult looking to make a difference? The NF Young Adult Leadership Program is your chance…
Read MoreThe European Commission has granted conditional approval for EZMEKLY® (mirdametinib) to treat symptomatic, inoperable plexiform neurofibromas (PNs) in patients aged…
Read MoreManaging NF1 PN can be complex! Hear from a Patient Education Manager to learn more about neurofibromatosis type 1 with…
Read More
© 2025 Neurofibromatosis Midwest - non profit 501(c)(t3). Site Map - Privacy Policy
The resources on this site should not be used as a substitute for professional medical care or advice on Neurofibromatosis. Users seeking information about a personal genetic disease, syndrome, or condition should consult with a qualified healthcare professional.